Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $186,284 | 98 | 59.0% |
| Consulting Fee | $84,071 | 41 | 26.6% |
| Travel and Lodging | $34,137 | 107 | 10.8% |
| Food and Beverage | $7,978 | 177 | 2.5% |
| Honoraria | $3,000 | 1 | 1.0% |
| Education | $22.39 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $102,680 | 142 | $0 (2021) |
| Covidien LP | $91,456 | 114 | $0 (2020) |
| GlaxoSmithKline, LLC. | $90,937 | 88 | $0 (2021) |
| Medtronic, Inc. | $13,260 | 18 | $0 (2024) |
| Varian Medical Systems, Inc. | $3,917 | 6 | $0 (2018) |
| Intuitive Surgical, Inc. | $3,202 | 16 | $0 (2021) |
| EKOS Corporation | $3,195 | 2 | $0 (2017) |
| ViiV Healthcare Company | $1,600 | 1 | $0 (2019) |
| Auris Health, Inc. | $1,590 | 10 | $0 (2019) |
| AstraZeneca UK Limited | $1,011 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,066 | 3 | Medtronic, Inc. ($2,040) |
| 2023 | $5,333 | 7 | Medtronic, Inc. ($4,250) |
| 2022 | $2,967 | 4 | Medtronic, Inc. ($2,890) |
| 2021 | $41,457 | 35 | GlaxoSmithKline, LLC. ($31,031) |
| 2020 | $84,673 | 75 | GlaxoSmithKline, LLC. ($48,306) |
| 2019 | $91,564 | 135 | AstraZeneca Pharmaceuticals LP ($64,048) |
| 2018 | $32,900 | 82 | AstraZeneca Pharmaceuticals LP ($13,454) |
| 2017 | $54,533 | 85 | Covidien LP ($48,728) |
All Payment Transactions
426 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Medtronic, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,275.00 | General |
| 11/02/2024 | Siemens Medical Solutions USA, Inc. | Cios Spin (Device) | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: AT - Mobile interventional x-ray/angiography fluoroscopy | ||||||
| 10/07/2024 | Medtronic, Inc. | — | Consulting Fee | Cash or cash equivalent | $765.00 | General |
| 11/20/2023 | Medtronic, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,190.00 | General |
| 10/12/2023 | Medtronic, Inc. | — | Consulting Fee | Cash or cash equivalent | $510.00 | General |
| 10/06/2023 | Noah Medical Corporation | — | Food and Beverage | Cash or cash equivalent | $129.49 | General |
| Category: Pulmonary Disease | ||||||
| 08/19/2023 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $18.06 | General |
| 08/18/2023 | GE HealthCare | — | Travel and Lodging | Cash or cash equivalent | $935.09 | General |
| 08/15/2023 | Medtronic, Inc. | — | Consulting Fee | Cash or cash equivalent | $765.00 | General |
| 03/24/2023 | Medtronic, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,785.00 | General |
| 11/08/2022 | Medtronic, Inc. | — | Consulting Fee | Cash or cash equivalent | $850.00 | General |
| 11/08/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $77.11 | General |
| Category: DIABETES | ||||||
| 06/20/2022 | Medtronic, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,020.00 | General |
| 04/25/2022 | Medtronic, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,020.00 | General |
| 12/07/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| Category: RESPIRATORY | ||||||
| 11/08/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: RESPIRATORY | ||||||
| 09/27/2021 | Medtronic, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,190.00 | General |
| 07/20/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: RESPIRATORY | ||||||
| 06/22/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: RESPIRATORY | ||||||
| 06/20/2021 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $1,011.00 | General |
| 06/15/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| Category: RESPIRATORY | ||||||
| 05/26/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $73.24 | General |
| Category: RESPIRATORY | ||||||
| 05/25/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| Category: RESPIRATORY | ||||||
| 05/25/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| Category: RESPIRATORY | ||||||
| 05/13/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $102.27 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 3 | 54 | 55 | $6,251 | $679.05 |
| 2020 | 17 | 779 | 849 | $256,659 | $46,103 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 24 | 25 | $2,193 | $250.14 | 11.4% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2021 | 12 | 12 | $1,647 | $243.52 | 14.8% |
| 94729 | Measurement of lung diffusing capacity | Office | 2021 | 18 | 18 | $2,411 | $185.39 | 7.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 138 | 161 | $21,730 | $8,791 | 40.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 121 | 137 | $21,006 | $6,414 | 30.5% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 144 | 163 | $13,473 | $5,257 | 39.0% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 69 | 69 | $15,758 | $4,637 | 29.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 41 | 50 | $11,232 | $3,753 | 33.4% |
| 31629 | Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | Facility | 2020 | 34 | 35 | $52,067 | $3,585 | 6.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 31 | 32 | $6,325 | $2,501 | 39.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 23 | 23 | $7,974 | $2,270 | 28.5% |
| 31652 | Examination of lung airways using an endoscope with imaging guidance and ultrasound | Facility | 2020 | 14 | 14 | $27,245 | $2,225 | 8.2% |
| 31627 | Computer-assisted image-guided navigation of lung airways using an endoscope | Facility | 2020 | 18 | 19 | $58,185 | $1,469 | 2.5% |
| 31633 | Needle biopsy of lung using an endoscope | Facility | 2020 | 23 | 23 | $4,343 | $1,171 | 27.0% |
| 94729 | Measurement of lung diffusing capacity | Office | 2020 | 33 | 33 | $4,420 | $989.46 | 22.4% |
| 94726 | Determination of lung volumes using plethysmography | Office | 2020 | 25 | 25 | $3,253 | $893.99 | 27.5% |
| 31654 | Examination of lung airways using an endoscope with imaging guidance and ultrasound | Facility | 2020 | 16 | 16 | $4,926 | $863.70 | 17.5% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2020 | 23 | 23 | $3,157 | $708.22 | 22.4% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 14 | 14 | $605.36 | $306.64 | 50.7% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2020 | 12 | 12 | $959.28 | $267.32 | 27.9% |
About Dr. Scott Skibo, MD
Dr. Scott Skibo, MD is a Pulmonary Disease healthcare provider based in Pinehurst, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1063431849.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Skibo, MD has received a total of $315,493 in payments from pharmaceutical and medical device companies, with $2,066 received in 2024. These payments were reported across 426 transactions from 20 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($186,284).
As a Medicare-enrolled provider, Skibo has provided services to 833 Medicare beneficiaries, totaling 904 services with total Medicare billing of $46,782. Data is available for 2 years (2020–2021), covering 20 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Pulmonary Disease
- Location Pinehurst, NC
- Active Since 07/19/2006
- Last Updated 02/16/2021
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1063431849
Products in Payments
- superDimension (Device) $81,372
- IMFINZI (Drug) $81,238
- TRELEGY ELLIPTA (Drug) $76,104
- ANORO ELLIPTA (Drug) $14,658
- TAGRISSO (Drug) $12,164
- SuperDimension (Device) $4,953
- Calypso (Device) $3,876
- Da Vinci Surgical System (Device) $3,202
- EKOSONIC (Device) $3,195
- Monarch (Device) $816.02
- Monarch Platform (Device) $332.03
- HealthMyne (Device) $309.89
- GENERAL PULMONARY (Device) $290.64
- Covidien (Device) $189.82
- BREO (Drug) $129.28
- ALAIR (Device) $108.13
- JARDIANCE (Drug) $77.11
- ACQUIRE (Device) $69.71
- Edge Navigation (Device) $56.09
- Edge (Device) $40.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Pinehurst
Michael Pritchett, D.o, D.O
Pulmonary Disease — Payments: $1.4M
Mr. Bradley Icard
Pulmonary Disease — Payments: $112,301
David Thornton, Md, MD
Pulmonary Disease — Payments: $10,742
Francis Collins, Md, MD
Pulmonary Disease — Payments: $1,742
Russell Miller, M.d, M.D
Pulmonary Disease — Payments: $1,181